IMPLANT SITE NERVE INJURY

This adverse event was reported 32 times

These drugs are most commonly taken by patients reporting IMPLANT SITE NERVE INJURY:

# Drug Count
0 ETONOGESTREL 20
1 VEDOLIZUMAB 2
2 ADALIMUMAB 1
3 CETIIRIZINE 1
4 CETIRIZINE 1
5 CETIRIZINE HYDROCHLORIDE 1
6 DROSPIRENONE AND ESTRADIOL 1
7 HUMAN C1-ESTERASE INHIBITOR 1
8 ORAL SEMAGLUTIDE 1
9 VANCOMYCIN 1
See all common drugs associated with IMPLANT SITE NERVE INJURY

IMPLANT SITE NERVE INJURY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DROSPIRENONE AND ESTRADIOL 1 0.0019
1 ETONOGESTREL 20 0.0003
2 VANCOMYCIN HYDROCHLORIDE 1 0.0001
3 HUMAN C1-ESTERASE INHIBITOR 1 0.0001
4 CETIIRIZINE 1 0.0000
5 VEDOLIZUMAB 2 0.0000
6 VANCOMYCIN 1 0.0000
7 ORAL SEMAGLUTIDE 1 0.0000
8 CETIRIZINE HYDROCHLORIDE 1 0.0000
9 ADALIMUMAB 1 0.0000
See all drugs enriched for association with IMPLANT SITE NERVE INJURY

IMPLANT SITE NERVE INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 21 0.0001
1 Integrin Receptor Antagonist [EPC] 2 0.0000
2 Glycopeptide Antibacterial [EPC] 1 0.0000
3 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
4 Estrogen [EPC] 1 0.0000
5 GLP-1 Receptor Agonist [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE NERVE INJURY